Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase III study of human prothrombin complex concentrate for on-demand treatment of bleeding in hemophilia B
CTR20243629Phase 3Completed
- Sponsor
- Sichuan Yuanda Shuyang Pharmaceutical
- Start
- Sep 2024
- Modality
- Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of balfaxar in hemophilia B (HB), sponsored by Sichuan Yuanda Shuyang Pharmaceutical. Started Sep 2024; status: completed.
02
Drugs
balfaxar
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on CTR20243629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243629.